Back in the 1990s, when I worked on structure data, I remember that at least some crystallizations were easy enough they could be done as a rotation project.
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6287266/ suggests that life is now a lot easier than the 1990s. Quoting the abstract:
> Macromolecular crystallography evolved enormously from the pioneering days, when structures were solved by “wizards” performing all complicated procedures almost by hand. In the current situation crystal structures of large systems can be often solved very effectively by various powerful automatic programs in days or hours, or even minutes. Such progress is to a large extent coupled to the advances in many other fields, such as genetic engineering, computer technology, availability of synchrotron beam lines and many other techniques, creating the highly interdisciplinary science of macromolecular crystallography. Due to this unprecedented success crystallography is often treated as one of the analytical methods and practiced by researchers interested in structures of macromolecules, but not highly competent in the procedures involved in the process of structure determination.
Certainly some proteins are extremely hard to crystallize, and the new single-atom EM work will help a lot. But are there really "armies of students who routinely spend 4-6 years of their PhD trying to solve a structure of a single protein" these days?
I honestly don't know. I'm sure some do. But if so, that army is pretty small compared to the vast numbers who more routinely use crystallography.
Anyway that anecdote is pretty much the entire sum of my protein crystallography knowledge, but perhaps it explains how your experience and GP's statement can both be true?
So your second guess is correct - one of the steps is much cheaper now, which marginally improves the entire pipeline. As a result, drugs should now arrive to the market faster.
As a side note, I am curious what happens to the field of structural biology in 10 to 15 years from now. Every research university has a large structural biology department with super expensive Xray/NRM/Cryo-EM machines, and armies of students who routinely spend 4-6 years of their PhD trying to solve a structure of a single protein. If AlphaFold works as advertised, NIH will gradually shift funding to other problems.
(It was predicted that it'd be taxi drivers, not professors, that AI got first. Ironic.)